INTRODUCTION
Microphthalmia and anophthalmia are at the severe end of the spectrum of abnormalities in ocular development. The combined occurrence rate for these two malformations is 1/10000 births ( , ). Mutations in several genes have been isolated in syndromic and 1 2 non-syndromic anophthalmia. Heterozygous mutations in account for approximately 10 of anophthalmia ( , ). Other genes have SOX2 % 3 4 been identified as causing anophthalmia or extreme microphthalmia in humans ( , , , , ) ( , ). These PAX6 OTX2 CHX10 STRA6 BMP4 5 6 latter are implicated in a very small proportion of affected individuals, implying wide genetic heterogeneity to match the phenotypic variability.
The homeobox gene is essential for vertebrate eye development. transcription begins in the anterior neural plate, then RAX RAX simultaneously in the eye field and in the ventral forebrain ( ). Even before , its expression is critical to defining the eye field during 7 PAX6
early development in animal models ( ). The lack of expression hampers optic vesicle formation and leads to brain size reduction in 8 RAX mouse, while ectopic expression induces the appearance and proliferation of retinal pigment epithelium cells in Xenopus ( ). The function 9
of the gene in eye development is yet not fully understood but there is additional evidence from animal studies that it is involved in RAX the proliferation of neural and retinal cells ( ). In humans, the role of in eye formation is clearly supported by the association of 10 RAX anophthalmia and sclerocornea in a patient bearing a truncating mutation and a missense mutation, both located in the DNA-binding helix of the homeodomain and reducing the DNA binding ability of the resulting protein ( ). We report here the case of a new patient with 11 bilateral anophthalmia associated with two distinct and novel truncating mutations of the gene. RAX scan showed bilateral absence of eyes with only fibrous tissue in the orbits ( ). Optic nerves and chiasma were hypoplastic. Fig. 1 Extraocular muscles appeared to be relatively preserved. The hypothalamus and pituitary gland were normal. No cerebral malformation was observed.
Molecular analysis
Parents gave their informed consent, according to French law, to participate in this study. DNA was isolated by standard procedures from peripheral white blood cells of the proband. Routine examination ruled out rearrangements or point mutations of and SOX2 PAX6
genes. The three exons, with exon-intron borders, were amplified by PCR using previously published primers ( ). PCR fragments RAX 11
were subsequently purified with QIAquick Gel Extraction kit (QIAGEN SA France), and both strands sequenced using Big Dye DNA sequencing kit (Applied Biosystems, UK). Reactions were analyzed in an ABI3100 sequencer (Applied Biosystems, UK). Sequence variations were numbered considering adenine of the ATG initiation codon as the first nucleotide (GenBank accession no. NM_013435.2).
The changes were verified by performing independent PCR and sequencing reactions on the proband s DNA. 
RESULTS
Sequence analysis of the proband s DNA revealed two novel mutations, both located in exon 3 of the gene. c.664delT
' RAX frameshifting deletion generates a premature stop codon (p.Ser222ArgfsX62). c.909C>G is a nonsense mutation, changing a tyrosine at position 303 to a stop codon (p.Tyr303X). These mutations were not found in a panel of 96 control chromosomes. Both are predicted to lead to a truncated protein so that, if not submitted to nonsense-mediated mRNA decay, the predicted RAX proteins lack the putative OAR ( ) transactivation domain and are non functional ( ). O tp, A ristaless, R ax 7
As this family left the country, DNA from the proband s parents was unavailable and thus segregation analysis of these two mutations ' was impossible. Nevertheless, the c.664delT and the c.909C>G mutations were shown to lie in , after sequencing of the cloned trans products of the patient s exon 3 ( ). ' RAX Figure 2 transcription factor, which in mice has a similar early role and an overlapping domain to that of but is downstream of and ( Rax Pax6 Otx2 ) and itself ( development, although she is too young to exclude the possibility of developmental delay and/or autistic features. Thus, phenotypic RAX spectrum is still unclear, and due to the limited number of cases reported so far, the existence of involvement in syndromic forms of RAX anophthalmia cannot be excluded. 
